INTT vs PFE · P/E 444, rev $33.9M vs P/E 20, rev $15.03B
inTest Corporation (INTT) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
inTest Corporation (INTT) is a semiconductor equipment & materials company listed on AMEX.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported INTT revenue for 2026-03-31 was $33.9M. Net income was $789.0K. Revenue was down 58.2% from 2025-09-30 to 2026-03-31. INTT currently screens at market cap $223.3M and trailing P/E 444.3.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
INTT currently screens at market cap $223.3M and trailing P/E 444.3. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the INTT and PFE stock pages for the full models.
Not investment advice.